4th Due Diligence Summit for Life Sciences Boston, Massachusetts, USA 18-19 May 2017

Description:
1. Create and deploy an effective gap analysis to help identify gaps in the product portfolio and regulatory standards.
2. Gain valuable insight from cross-functional due diligence team members, as well as leaders in the medical device and biotech industries.
3. Understand how to develop strategic objectives for a deal and accelerate synergies to ensure a high-performance organization.
4. Learn how to evaluate and effectively manage strategic alliances through case studies from industry leaders.
5. Evaluate the scope, validity and enforceability of a target’s patents.

Price:
Early Bird Pricing — Register by March 31, 2017 - Conference: USD1.895
Standard Pricing - Conference: USD2.095

Speakers: Robert Bagdorf, M.D., MBA, Catherine Baillis, Joseph Bulvid, John Dougherty, Luba Greenwood, Matthew Handel, Diane Harvey, Ph.D., Courtney Horvath, Ph.D., DABT, Michael B. Kennedy II, Curt H. LaBelle, M.D., MBA, Lizabeth Leveille, Edward Mahony, Mike Myers, Marc Schwabish, David Shoultz, Ph.D., M.S., MBA, Allan Weber